Signal Advisors Wealth LLC Sells 2,566 Shares of Cigna Group $CI

Signal Advisors Wealth LLC lowered its stake in Cigna Group (NYSE:CI) by 46.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,927 shares of the health services provider’s stock after selling 2,566 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Cigna Group were worth $844,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in CI. Flaharty Asset Management LLC acquired a new position in Cigna Group in the first quarter valued at about $28,000. 1248 Management LLC acquired a new position in shares of Cigna Group during the 1st quarter worth about $29,000. Solstein Capital LLC bought a new stake in shares of Cigna Group in the 2nd quarter valued at about $29,000. Chilton Capital Management LLC acquired a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $30,000. Finally, Activest Wealth Management boosted its stake in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after acquiring an additional 72 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $272.11 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. The firm has a market cap of $72.69 billion, a price-to-earnings ratio of 12.00, a price-to-earnings-growth ratio of 0.99 and a beta of 0.26. The stock’s 50-day moving average is $277.41 and its 200-day moving average is $292.67. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period last year, the company earned $7.51 earnings per share. Cigna Group’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th were issued a $1.51 dividend. The ex-dividend date was Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CI. TD Cowen lowered their target price on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. Cowen set a $333.00 target price on Cigna Group in a report on Monday, December 15th. Finally, Wolfe Research lowered their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $331.83.

Insiders Place Their Bets

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.